MENU
+Compare
ANSLY
Stock ticker: OTC
AS OF
Aug 5 closing price
Price
$79.00
Change
-$0.49 (-0.62%)
Capitalization
3.29B

ANSLY stock forecast, quote, news & analysis

Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment... Show more

ANSLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for ANSLY with price predictions
Sep 04, 2025

Momentum Indicator for ANSLY turns positive, indicating new upward trend

ANSLY saw its Momentum Indicator move above the 0 level on August 19, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 71 similar instances where the indicator turned positive. In of the 71 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where ANSLY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ANSLY just turned positive on August 22, 2025. Looking at past instances where ANSLY's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

ANSLY moved above its 50-day moving average on September 04, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Aroon Indicator for ANSLY entered a downward trend on September 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.468) is normal, around the industry mean (10.922). P/E Ratio (28.417) is within average values for comparable stocks, (59.257). ANSLY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.725). Dividend Yield (0.025) settles around the average of (0.016) among similar stocks. P/S Ratio (1.441) is also within normal values, averaging (13.293).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ANSLY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANSLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I.Advisor
published Dividends

ANSLY is expected to pay dividends on October 03, 2025

Ansell Ltd. ANSLY Stock Dividends
A dividend of $1.12 per share will be paid with a record date of October 03, 2025, and an ex-dividend date of September 04, 2025. The last dividend of $1.77 was paid on March 21. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 10.95B. The market cap for tickers in the group ranges from 246 to 162.93B. ISRG holds the highest valuation in this group at 162.93B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -1%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 19%. ZTEK experienced the highest price growth at 31%, while STSS experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -17%. For the same stocks of the Industry, the average monthly volume growth was -55% and the average quarterly volume growth was -25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 64
Price Growth Rating: 60
SMR Rating: 81
Profit Risk Rating: 91
Seasonality Score: -31 (-100 ... +100)
View a ticker or compare two or three
ANSLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
678 Victoria Street
Phone
+61 392707270
Employees
14414
Web
https://www.ansell.com